Overview
McDermott Will & Emery advised Lauxera Capital Partners on its investment in Acandis, a leading German neurovascular medical device company dedicated to the prevention and treatment of stroke.
Lauxera Capital Partners’ Acandis transaction is the firm’s first investment out of Lauxera Growth II, its second-generation healthcare growth buyout fund.
The McDermott team on this transaction was composed of:
France
Corporate
Grégoire Andrieux – Partner
Fanny Rech – Counsel
Boris Wolkoff – Associate
Alexandre Bomet – Associate
Ruben Johannsen – Juriste
Tax
Antoine Vergnat – Partner
Paul-Henry de Laguiche – Associate
Competition
Frédéric Pradelles – Partner
Mary Hecht – Associate
Francesca Casalone – Associate
Germany
Corporate
Holger Ebersberger -Partner
Alexandra Prato – Counsel
Marion Dalvai-König – Associate
Parsin Walsi – Associate
Tax
Heiko Kermer – Partner
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
